UBS Cuts Boston Scientific Price Target to $57 From $67
UBS lowered its price target on Boston Scientific (BSX) shares to $57 from $67 and kept a Buy rating. Citigroup cut its target to $44 from $48.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
UBS lowered its price target on Boston Scientific shares to $57 a share from $67, while keeping its Buy rating on the stock. The move was reported by Dow Jones Newswires, citing Benzinga.
Citigroup also reduced its price target on the company's shares, to $44 a share from $48. The report was published at 19:30 GMT.
why it matters
A price target cut reflects analysts' valuation views rather than new reported results. Such changes usually shape sentiment around the stock, especially when several brokers lower their targets at the same time.
tags
instruments
sources
- Boston Scientific Price Target Cut to $57.00/Share From $67.00 by UBS — Dow Jones Newswires, 29 October 2026 at 18:35 UTC
- Boston Scientific Price Target Cut to $44.00/Share From $48.00 by Citigroup — Dow Jones Newswires, 29 October 2026 at 19:30 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗